| # | Drug | Count |
|---|---|---|
| 0 | CISPLATIN | 161 |
| 1 | ETOPOSIDE | 136 |
| 2 | CARBOPLATIN | 92 |
| 3 | TACROLIMUS | 27 |
| 4 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 26 |
| 5 | TACROLIMUS OINTMENT 0.1% | 26 |
| 6 | PREDNISOLONE | 22 |
| 7 | PREDNISOLONE ORAL | 22 |
| 8 | PREDNISOLONE ORAL SOLUTION | 22 |
| 9 | FLUOROURACIL | 19 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ADEFOVIR DIPIVOXIL | 3 | 0.0024 |
| 1 | CISPLATIN | 161 | 0.0020 |
| 2 | ETOPOSIDE | 136 | 0.0019 |
| 3 | CALCIUM POLYCARBOPHIL | 3 | 0.0010 |
| 4 | FERRIC CARBOXYMALTOSE | 4 | 0.0008 |
| 5 | BLEOMYCIN SULFATE | 8 | 0.0008 |
| 6 | CARBOPLATIN | 92 | 0.0007 |
| 7 | MANNITOL | 3 | 0.0006 |
| 8 | HALOPERIDOL DECANOATE | 1 | 0.0006 |
| 9 | MITOTANE | 1 | 0.0005 |
| # | Drug class | Count |
|---|---|---|
| 0 | Platinum-based Drug [EPC] | 255 |
| 1 | Topoisomerase Inhibitor [EPC] | 136 |
| 2 | Corticosteroid [EPC] | 60 |
| 3 | Nucleoside Metabolic Inhibitor [EPC] | 33 |
| 4 | Alkylating Drug [EPC] | 26 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 14 |
| 6 | Nonsteroidal Anti-inflammatory Drug [EPC] | 14 |
| 7 | Microtubule Inhibitor [EPC] | 10 |
| 8 | Osmotic Laxative [EPC] | 10 |
| 9 | Kinase Inhibitor [EPC] | 9 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Topoisomerase Inhibitor [EPC] | 136 | 0.0018 |
| 1 | Platinum-based Drug [EPC] | 255 | 0.0009 |
| 2 | Osmotic Diuretic [EPC] | 3 | 0.0006 |
| 3 | Actinomycin [EPC] | 1 | 0.0005 |
| 4 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 3 | 0.0003 |
| 5 | Lipid-based Polyene Antifungal [EPC] | 3 | 0.0002 |
| 6 | Antiseptic [EPC] | 1 | 0.0002 |
| 7 | Oxazolidinone Antibacterial [EPC] | 6 | 0.0002 |
| 8 | Phenothiazine [EPC] | 5 | 0.0002 |
| 9 | Nucleoside Metabolic Inhibitor [EPC] | 33 | 0.0001 |